Horizon’s Saint John Regional Hospital to become Canada’s first to adopt Subtle Medical’s AI solutions

Subtle Medical, a healthcare technology company using artificial intelligence to improve medical imaging, announced today the first commercial adoption of SubtlePET™ in Canada to help improve the quality and efficiency of PET imaging.

The launch was made possible by support from the Saint John Regional Hospital Foundation, a charitable organization focused on providing exceptional health care in New Brunswick.

Through the Foundation’s Medical Competition, funding was made available for the adoption of Subtle Medical’s deep learning technology, SubtlePET™, which earned recognition after demonstrating the ability to dramatically improve patient comfort and safety during medical imaging by giving imaging institutions the ability to restore image quality to standard of care when conducting shorter and lower dose PET exams.

“Our doctors and healthcare workers are constantly looking for ways to bring medical innovation and new clinical programs to life. They are backed by an ambitious and progressive foundation that’s continually striving to support them by investing in healthcare innovation for the benefit of all New Brunswickers. We look forward to seeing these new innovations in practice,” says Jamie Gallagher, President & CEO for the Foundation.

Shorter scan times are particularly beneficial to children and patients who experience pain and anxiety during these procedures. Reducing scan times could also allow institutions to schedule more patients a day on their existing scanners, resulting in shorter wait times for patients in critical need of medical imaging.

“The launch of Subtle’s AI solutions is one step further in supporting Horizon’s goal of prioritizing patient-centered care,” said Zach Kilburn, Regional Director of Diagnostic Imaging for Horizon Health Network. “The SubtlePET technology not only improves patient experience during procedures, but also allows us to see more patients, creating a better, more efficient imaging program at our center.”

“We are grateful for the support from The Saint John Regional Hospital Foundation and proud that Horizon Health Network is the first to use Subtle Medical’s AI solutions in Canada,” said Josh Gurewitz, Chief Commercial Officer at Subtle Medical. “The Canadian healthcare system is among the best in the world, so it’s only natural that hospitals and medical centers recognize the critical role AI plays in improving healthcare inefficiencies and providing the highest level of care to their patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version